ENDRA Life SciencesNASDAQ: NDRA

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced today that it has priced a public offering with gross proceeds to the Company expected to be approximately $8.0 million, before deducting placement agent fees and other estimated expenses payable by the Company. The offering is a best-efforts offering, with no minimum amount of securities required to be sold. The offering is.

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best will host a complimentary webinar titled “The Case for Engaging Defense Counsel Pre-Lawsuit,” on June 25, 2024, at 2:00 p.m. ET. In this webinar, sponsored by Three Griffins, Inc., a panel of insurance claims experts will examine the path from claim to lawsuit, and best practices on minimizing loss through appropriate legal consultation. Register now. Panelists include: Daniel Herbert, president/CEO, Three Griffins, Inc. Donald J. Richardson, shareholder,.

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q1 2024 Earnings Call Transcript May 14, 2024 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and CEO Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director of Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Welcome to the ENDRA Life Sciences First Quarter 2024 Financial Results Conference call. All participants will be in a listen-only mode.

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q3 2023 Results Conference Call November 14, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Third Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode.

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.